257 related articles for article (PubMed ID: 31914198)
1. Molecular Characterization and Treatment of Pancreatic Neuroendocrine Tumors.
De Jesus-Acosta AMC
Oncology (Williston Park); 2019 Dec; 33(12):. PubMed ID: 31914198
[No Abstract] [Full Text] [Related]
2. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.
Falconi M; Eriksson B; Kaltsas G; Bartsch DK; Capdevila J; Caplin M; Kos-Kudla B; Kwekkeboom D; Rindi G; Klöppel G; Reed N; Kianmanesh R; Jensen RT;
Neuroendocrinology; 2016; 103(2):153-71. PubMed ID: 26742109
[No Abstract] [Full Text] [Related]
3. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Oberg K; Jelic S;
Ann Oncol; 2008 May; 19 Suppl 2():ii104-5. PubMed ID: 18456741
[No Abstract] [Full Text] [Related]
4. Genetics of pancreatic neuroendocrine tumors: implications for the clinic.
Pea A; Hruban RH; Wood LD
Expert Rev Gastroenterol Hepatol; 2015; 9(11):1407-19. PubMed ID: 26413978
[TBL] [Abstract][Full Text] [Related]
5. [Neuroendocrine tumors of the pancreas. Natural history and therapeutic options].
Wiedenmann B
Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S26-30. PubMed ID: 12704290
[No Abstract] [Full Text] [Related]
6. Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors.
Lin LY; Yeh YC; Chu CH; Won JGS; Shyr YM; Chao Y; Li CP; Wang SE; Chen MH
Medicine (Baltimore); 2017 Oct; 96(41):e8262. PubMed ID: 29019897
[TBL] [Abstract][Full Text] [Related]
7. New Genetics and Genomic Data on Pancreatic Neuroendocrine Tumors: Implications for Diagnosis, Treatment, and Targeted Therapies.
Schmitt AM; Marinoni I; Blank A; Perren A
Endocr Pathol; 2016 Sep; 27(3):200-4. PubMed ID: 27456058
[TBL] [Abstract][Full Text] [Related]
8. [Current status and therapeutic strategy for pancreatic neuroendocrine tumors in Japan].
Ito T; Igarashi H; Jensen RT; Takayanagi R
Fukuoka Igaku Zasshi; 2012 Jul; 103(7):131-7. PubMed ID: 22978065
[No Abstract] [Full Text] [Related]
9. Do morphologic characteristics play a role in nodal metastatic progression of well-differentiated pancreatic neuroendocrine tumors?
Ugras N; Hasdemir S; Yerci Ö; Taşar P; Dündar HZ; Macunluoğlu AC
Tumori; 2021 Feb; 107(1):80-85. PubMed ID: 32705937
[TBL] [Abstract][Full Text] [Related]
10. Occipital Headache as Initial Manifestation of a Pancreatic Neuroendocrine Tumor.
Tsoukalas N; Triantafyllidis A; Tolia M; Galanopoulos M; Kostakis ID; Demiri S; Toumpanakis C; Koumakis G
J Gastrointest Cancer; 2018 Dec; 49(4):501-503. PubMed ID: 28283989
[No Abstract] [Full Text] [Related]
11. Cases in the Management of GEP-NETs: Combination Regimens.
Braiteh F
Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):11-3. PubMed ID: 27167993
[No Abstract] [Full Text] [Related]
12. Pancreatic neuroendocrine tumors.
Krampitz GW; Norton JA
Curr Probl Surg; 2013 Nov; 50(11):509-45. PubMed ID: 24206780
[No Abstract] [Full Text] [Related]
13. Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.
Ma ZY; Gong YF; Zhuang HK; Zhou ZX; Huang SZ; Zou YP; Huang BW; Sun ZH; Zhang CZ; Tang YQ; Hou BH
World J Gastroenterol; 2020 May; 26(19):2305-2322. PubMed ID: 32476795
[TBL] [Abstract][Full Text] [Related]
14. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.
Klöppel G; Couvelard A; Perren A; Komminoth P; McNicol AM; Nilsson O; Scarpa A; Scoazec JY; Wiedenmann B; Papotti M; Rindi G; Plöckinger U; ;
Neuroendocrinology; 2009; 90(2):162-6. PubMed ID: 19060454
[No Abstract] [Full Text] [Related]
15. Neuroendocrine Tumors--Current and Future Clinical Advances.
Chan JA; Kulke MH
Hematol Oncol Clin North Am; 2016 Feb; 30(1):xiii-xiv. PubMed ID: 26614379
[No Abstract] [Full Text] [Related]
16. Biology and Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors.
Raj N; Fazio N; Strosberg J
Am Soc Clin Oncol Educ Book; 2018 May; 38():292-299. PubMed ID: 30231344
[TBL] [Abstract][Full Text] [Related]
17. Aggressive gastro-entero-pancreatic neoplasms.
Coriat R
Ann Endocrinol (Paris); 2019 Jun; 80(3):185-186. PubMed ID: 31064660
[No Abstract] [Full Text] [Related]
18. Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.
Jensen RT; Norton JA
Pancreas; 2017; 46(5):589-594. PubMed ID: 28426491
[No Abstract] [Full Text] [Related]
19. Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment.
Baur AD; Pavel M; Prasad V; Denecke T
Acta Radiol; 2016 Mar; 57(3):260-70. PubMed ID: 25855665
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Öberg K; Knigge U; Kwekkeboom D; Perren A;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii124-30. PubMed ID: 22997445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
